Absorbable lung sealant gets European launch:
This article was originally published in Clinica
Focal is launching its FocalSeal surgical sealant, in Europe. Marketed as AdvaSeal, the product is claimed to be the world's first synthetic, absorbable sealant. It is to be used for lung surgery and will be sold in the European Union countries through Johnson & Johnson's Ethicon subsidiary. AdvaSeal is used in post-operative air leaks in lung cancer and other lung operations.
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.